Anthony A. Meluch
Sarah Cannon Cancer Center
Nashville
USA
Name/email consistency: high
- Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial. Meluch, A.A., Greco, F.A., Morrissey, L.H., Raefsky, E.L., Steis, R.G., Butts, J.A., Hainsworth, J.D. Cancer (2003)
- Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network. Meluch, A.A., Greco, F.A., Burris, H.A., O'Rourke, T., Ortega, G., Steis, R.G., Morrissey, L.H., Johnson, V., Hainsworth, J.D. J. Clin. Oncol. (2001)